Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christine Essner"'
Autor:
Delphine Loirat, Marie Duboys de Labarre, Christine Essner, Ioana Hrab, Jean-Christophe Thery, Christelle Jouannaud, Cristian Villanueva, Perrine Vuagnat, Pauline Soibinet-Oudot, Anne Creisson, Audrey Mailliez, Jean-Loup Mouysset, Laura Salabert, Nadine Dohollou, Jean-David Fumet, Thibault De La Motte Rouge, Jean-Michel Vauthier, Maylis Decrop, Pascal Pujol
Publikováno v:
Cancer Research. 82:P1-18
Background: Talazoparib (TALA) is a highly potent PARP inhibitor that has demonstrated clinical benefit in the phase III EMBRACA trial for patients with germline BRCA1 or BRCA2-mutation and a locally advanced or metastatic HER2 negative (HER2-) breas
Autor:
Olivier Bouché, Claire Carlier, Christine Essner, Adeline Debreuve-Theresette, Mathias Brugel, Yacine Merrouche, Marie Françoise Beck
Publikováno v:
The Oncologist
Oncologist
Oncologist
The coronavirus disease 2019 (COVID-19) pandemic may have affected cancer management. We aimed to evaluate changes in every oncology care pathway essential step, from screening to treatment, during the pandemic. Monthly oncological activity differenc
Autor:
Martin, Sophie, Kaeuffer, Charlotte, Leyendecker, Pierre, Tuzin, Nicolas, Tazi, Youssef, Schaff‐Wendling, Frédérique, Kleinheny, Tiffanie, Husson‐Wetzel, Stéphanie, Pamart, Guillaume, Limacher, Jean‐Marc, Clerc, Olivier, Dicop, Elise, Kurtz, Jean‐Emmanuel, Barthélémy, Philippe, Gantzer, Justine
Publikováno v:
Oncologist; Sep2021, Vol. 26 Issue 9, pe1656-e1659, 4p, 2 Charts
Autor:
Brugel, Mathias, Carlier, Claire, Essner, Christine, Debreuve‐Theresette, Adeline, Beck, Marie‐Françoise, Merrouche, Yacine, Bouché, Olivier
Publikováno v:
Oncologist; Feb2021, Vol. 26 Issue 2, pe338-e341, 4p, 1 Chart, 1 Graph